| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A minimalist fragment approach for the design of natural-product-like synthetic scaffolds
|
Genis, Dmitry
|
|
2012
|
17 |
21-22 |
p. 1170-1174
5 p.
|
artikel
|
| 2 |
Contents
|
|
|
2012
|
17 |
21-22 |
p. iii-
1 p.
|
artikel
|
| 3 |
Contents
|
|
|
2012
|
17 |
21-22 |
p. i-
1 p.
|
artikel
|
| 4 |
Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design
|
Hosseinimehr, Seyed Jalal
|
|
2012
|
17 |
21-22 |
p. 1224-1232
9 p.
|
artikel
|
| 5 |
Nucleic acid sample preparation for in vitro molecular diagnosis: from conventional techniques to biotechnology
|
Rahman, Md Mahbubor
|
|
2012
|
17 |
21-22 |
p. 1199-1207
9 p.
|
artikel
|
| 6 |
Open PHACTS: semantic interoperability for drug discovery
|
Williams, Antony J.
|
|
2012
|
17 |
21-22 |
p. 1188-1198
11 p.
|
artikel
|
| 7 |
Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases
|
Mei, Hongkang
|
|
2012
|
17 |
21-22 |
p. 1208-1216
9 p.
|
artikel
|
| 8 |
PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET
|
Slobbe, Paul
|
|
2012
|
17 |
21-22 |
p. 1175-1187
13 p.
|
artikel
|
| 9 |
Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare
|
Wellenreuther, Ruth
|
|
2012
|
17 |
21-22 |
p. 1242-1248
7 p.
|
artikel
|
| 10 |
Targeting mutant huntingtin for the development of disease-modifying therapy
|
Appl, Thomas
|
|
2012
|
17 |
21-22 |
p. 1217-1223
7 p.
|
artikel
|
| 11 |
The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease
|
’t Hart, Bert A.
|
|
2012
|
17 |
21-22 |
p. 1160-1165
6 p.
|
artikel
|
| 12 |
Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents
|
Kumar, Ajay
|
|
2012
|
17 |
21-22 |
p. 1233-1241
9 p.
|
artikel
|
| 13 |
What are the prospects of slowing the progression of Alzheimer's disease?
|
Palmer, Alan M.
|
|
2012
|
17 |
21-22 |
p. 1157-1159
3 p.
|
artikel
|
| 14 |
What is the most important approach in current drug discovery: doing the right things or doing things right?
|
Elebring, Thomas
|
|
2012
|
17 |
21-22 |
p. 1166-1169
4 p.
|
artikel
|
Tijdschrift beschrijving